A meta-analysis found subtle heart muscle dysfunction in people with HIV despite normal ejection fraction, highlighting the ...

In an HIV prevention trial, an antibody blocked the viruses most vulnerable to it, but others broke through. Now researchers have uncovered how HIV evolved after those infections—and why the amount of ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. A new sequential immunization strategy shows strong promise for an HIV vaccine, a ...

A retrospective cohort of 112 HIV patients in Shiraz, Iran, found that 46 percent had CD4+ T-cell counts below 200 cells per ...

Written By Christian Castro Every year, Latine people have the highest number of new HIV diagnoses in the United States, ...

OPINION: New tools can transform HIV prevention and treatment. Their reach depends on confronting the barriers that keep people from care.

Sara Moniuszko is a health and lifestyle reporter at CBSNews.com. Previously, she wrote for USA Today, where she was selected to help launch the newspaper's wellness vertical. She now covers breaking ...

Misinformation around human immunodeficiency virus (HIV) often circulates in Muslim-majority Indonesia, with the latest posts ...

Gilead's twice-yearly shot reduced HIV infections by 96% in a second large study, the company said. The data sets the stage for likely FDA approval of lenacapavir for HIV prevention. Shares rose 3% in ...

A study in Botswana finds that long-term antiretroviral therapy does not appear to lower the risk for anogenital cancer among ...

In the early decades of the global response to HIV/AIDS, the focus was on saving lives. And rightly so: without antiretroviral treatment (ART), people lived less than a year, on average, from the time ...